Quanterix Corp

NASDAQ:QTRX 4:00:00 PM EDT

6.69

+0.04 (+0.60%)

6:29:49 PM EDT: $6.77 +0.08 (+1.14%)

Market Cap (Intraday)	259.94M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$29.46 Million
Adjusted EPS	-$0.40

See more estimates

10-Day MA	$6.39
50-Day MA	$5.60
200-Day MA	$9.02

See more pivots

Quanterix Corp Stock, NASDAQ:QTRX

Building 1, 900 Middlesex Turnpike, Billerica, Massachusetts 01821

United States of America

Phone: +1.617.301.9400

Number of Employees:

http://www.quanterix.com

Description

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.